Engineering liver disease models in vitro: emerging trends and innovations
Qi Rao(Huanggang Central Hospital), Nan Ma(Jiangsu University of Science and Technology), Adrien Guillot(Charité - Universitätsmedizin Berlin), Frank Tacke(Charité - Universitätsmedizin Berlin), Lei Wang(Helmholtz-Zentrum Hereon)
Cited by 2
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
|Hepatology|2010|786